Assenagon Asset Management S.A. Sells 22,729 Shares of Teleflex Incorporated (NYSE:TFX)

Assenagon Asset Management S.A. trimmed its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 50.5% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 22,287 shares of the medical technology company's stock after selling 22,729 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Teleflex were worth $3,080,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. CANADA LIFE ASSURANCE Co lifted its stake in Teleflex by 0.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock worth $3,614,000 after purchasing an additional 74 shares during the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 100 shares during the last quarter. True Wealth Design LLC boosted its holdings in Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock valued at $48,000 after acquiring an additional 104 shares during the period. Isthmus Partners LLC grew its position in Teleflex by 7.3% during the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock worth $273,000 after acquiring an additional 105 shares during the last quarter. Finally, QRG Capital Management Inc. increased its stake in Teleflex by 5.8% in the 4th quarter. QRG Capital Management Inc. now owns 2,178 shares of the medical technology company's stock worth $388,000 after purchasing an additional 119 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on TFX shares. Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and cut their target price for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Wall Street Zen lowered shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Morgan Stanley lowered their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Mizuho set a $155.00 target price on shares of Teleflex in a report on Wednesday, April 16th. Finally, Royal Bank Of Canada cut their target price on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $164.63.

Teleflex Stock Up 0.2%

Teleflex stock traded up $0.25 during trading hours on Friday, hitting $117.97. 259,310 shares of the stock traded hands, compared to its average volume of 867,676. Teleflex Incorporated has a one year low of $116.60 and a one year high of $249.90. The company has a market cap of $5.21 billion, a PE ratio of 37.21, a PEG ratio of 1.84 and a beta of 1.10. The firm's 50-day moving average price is $125.67 and its two-hundred day moving average price is $150.62. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. During the same quarter in the prior year, the company earned $3.21 earnings per share. The firm's quarterly revenue was down 5.0% compared to the same quarter last year. On average, research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Tuesday, May 20th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.15%. The ex-dividend date of this dividend was Tuesday, May 20th. Teleflex's payout ratio is currently 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.